$ALOT
AstroNova, Inc. Stock $alot

$alot Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-Q Financial Statement

#000119312514336721 Filed on September 09, 2014

Income Statement

Concept	2014 Q3	2013 Q3
Revenue	$22.37M	$17.19M
YoY Change	30.08%	17.26%
Cost Of Revenue	$12.78M	$10.27M
YoY Change	24.4%	12.79%
Gross Profit	$9.589M	$6.923M
YoY Change	38.51%	24.58%
Gross Profit Margin	42.87%	40.26%
Selling, General & Admin	$5.946M	$4.762M
YoY Change	24.86%	15.92%
% of Gross Profit	62.01%	68.79%
Research & Development	$1.479M	$1.274M
YoY Change	16.09%	43.95%
% of Gross Profit	15.42%	18.4%
Depreciation & Amortization	$530.0K	$330.0K
YoY Change	60.61%	-5.71%
% of Gross Profit	5.53%	4.77%
Operating Expenses	$7.425M	$6.036M
YoY Change	23.01%	20.89%
Operating Profit	$2.164M	$887.0K
YoY Change	143.97%	57.27%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$83.00K	-$25.00K
YoY Change	-432.0%	-71.91%
Pretax Income	$2.247M	$862.0K
YoY Change	160.67%	81.47%
Income Tax	$812.0K	$331.0K
% Of Pretax Income	36.14%	38.4%
Net Earnings	$1.435M	$696.0K
YoY Change	106.18%	-29.48%
Net Earnings / Revenue	6.42%	4.05%
Basic Earnings Per Share	$0.19	$0.09
Diluted Earnings Per Share	$0.18	$0.09
COMMON SHARES
Basic Shares Outstanding	7.704M shares	7.458M shares
Diluted Shares Outstanding	7.916M shares	7.655M shares

Balance Sheet

Concept	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.00M	$32.60M
YoY Change	-14.11%	44.89%
Cash & Equivalents	$13.20M	$12.18M
Short-Term Investments	$14.80M	$20.40M
Other Short-Term Assets	$8.000M	$11.10M
YoY Change	-27.93%	226.47%
Inventory	$16.02M	$12.51M
Prepaid Expenses
Receivables	$14.08M	$9.674M
Other Receivables	$400.0K	$500.0K
Total Short-Term Assets	$66.56M	$66.47M
YoY Change	0.12%	28.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.783M	$7.490M
YoY Change	3.91%	-30.65%
Goodwill	$991.0K	$795.0K
YoY Change	24.65%
Intangibles	$3.049M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$400.0K	$100.0K
YoY Change	300.0%	0.0%
Total Long-Term Assets	$4.718M	$1.462M
YoY Change	222.71%	-89.63%
TOTAL ASSETS
Total Short-Term Assets	$66.56M	$66.47M
Total Long-Term Assets	$4.718M	$1.462M
Total Assets	$79.06M	$75.43M
YoY Change	4.82%	14.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.754M	$2.289M
YoY Change	20.31%	9.0%
Accrued Expenses	$5.300M	$6.000M
YoY Change	-11.67%	50.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.617M	$10.24M
YoY Change	-15.82%	50.54%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$0.00
YoY Change
Other Long-Term Liabilities	$1.000M	$1.300M
YoY Change	-23.08%	44.44%
Total Long-Term Liabilities	$1.100M	$1.300M
YoY Change	-15.38%	44.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.617M	$10.24M
Total Long-Term Liabilities	$1.100M	$1.300M
Total Liabilities	$9.837M	$11.82M
YoY Change	-16.75%	25.7%
SHAREHOLDERS EQUITY
Retained Earnings	$38.69M	$35.29M
YoY Change	9.63%
Common Stock	$475.0K	$457.0K
YoY Change	3.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$13.09M	$11.72M
YoY Change	11.7%
Treasury Stock Shares	1.776M shares	1.668M shares
Shareholders Equity	$69.22M	$63.61M
YoY Change
Total Liabilities & Shareholders Equity	$79.06M	$75.43M
YoY Change	4.82%	14.63%

Cashflow Statement

Concept	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	$1.435M	$696.0K
YoY Change	106.18%	-29.48%
Depreciation, Depletion And Amortization	$530.0K	$330.0K
YoY Change	60.61%	-5.71%
Cash From Operating Activities	-$160.0K	$780.0K
YoY Change	-120.51%
INVESTING ACTIVITIES
Capital Expenditures	-$580.0K	-$260.0K
YoY Change	123.08%	100.0%
Acquisitions
YoY Change
Other Investing Activities	$3.820M	-$110.0K
YoY Change	-3572.73%	-111.96%
Cash From Investing Activities	$3.230M	-$360.0K
YoY Change	-997.22%	-145.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-300.0K	-430.0K
YoY Change	-30.23%	-14.0%
NET CHANGE
Cash From Operating Activities	-160.0K	780.0K
Cash From Investing Activities	3.230M	-360.0K
Cash From Financing Activities	-300.0K	-430.0K
Net Change In Cash	2.770M	-10.00K
YoY Change	-27800.0%	-103.45%
FREE CASH FLOW
Cash From Operating Activities	-$160.0K	$780.0K
Capital Expenditures	-$580.0K	-$260.0K
Free Cash Flow	$420.0K	$1.040M
YoY Change	-59.62%	700.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	alot	Debt Received Upon Sale Of Operation DebtReceivedUponSaleOfOperation	1000000
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7720285	shares
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12183000
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	442243	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9494748	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	84745	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.81
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	693317	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.64
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1776121	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.43
CY2014Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1028000
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28057000
CY2014Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2481000
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	43015000
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2754000
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8617000
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	133000
CY2014Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	651000
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2784000
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	69221000
CY2014Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	38689000
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	469000
CY2014Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	129000
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	475000
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79058000
CY2014Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	88000
CY2014Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3784000
CY2014Q3	us-gaap	Liabilities Liabilities	9837000
CY2014Q3	us-gaap	Assets Current AssetsCurrent	66557000
CY2014Q3	us-gaap	Goodwill Goodwill	991000
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3049000
CY2014Q3	us-gaap	Financial Instruments Owned State And Municipal Government Obligations At Fair Value FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue	14808000
CY2014Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	14808000
CY2014Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1132000
CY2014Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	315000
CY2014Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	270000
CY2014Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8835000
CY2014Q3	us-gaap	Assets Assets	79058000
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13199000
CY2014Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	10766000
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14075000
CY2014Q3	us-gaap	Inventory Net InventoryNet	16023000
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35840000
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1975000
CY2014Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	4718000
CY2014Q3	us-gaap	Inventory Gross InventoryGross	19807000
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4205000
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2423000
CY2014Q3	us-gaap	Other Assets OtherAssets	93000
CY2014Q3	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	2120000
CY2014Q3	us-gaap	Notes Receivable Net NotesReceivableNet	562500
CY2014Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000
CY2014Q3	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	23643000
CY2014Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1677000
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	13091000
CY2014Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7909000
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7783000
CY2014Q3	alot	Line Of Credit Receivable Current LineOfCreditReceivableCurrent	200000
CY2014Q3	alot	Product Replacement Reserve ProductReplacementReserve	416000
CY2014Q3	alot	Contract Related To Noncompete Agreement ContractRelatedToNoncompeteAgreement	104000
CY2014Q3	alot	Product Replacement Cost Charged Against Reserve ProductReplacementCostChargedAgainstReserve	256000
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30999000
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9291225	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	106496	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.63
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	736647	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1730042	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.12
CY2014Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1131000
CY2014Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27368000
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2310000
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41235000
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2374000
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9892000
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	176000
CY2014Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	715000
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3130000
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	66614000
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	37201000
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	454000
CY2014Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	788000
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	465000
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77964000
CY2014Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	77000
CY2014Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3194000
CY2014Q1	us-gaap	Liabilities Liabilities	11350000
CY2014Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	836000
CY2014Q1	us-gaap	Assets Current AssetsCurrent	65034000
CY2014Q1	us-gaap	Goodwill Goodwill	991000
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3400000
CY2014Q1	us-gaap	Financial Instruments Owned State And Municipal Government Obligations At Fair Value FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue	18766000
CY2014Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	18766000
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1800000
CY2014Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	852000
CY2014Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	440000
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	313000
CY2014Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4734000
CY2014Q1	us-gaap	Assets Assets	77964000
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8341000
CY2014Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	10722000
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11366000
CY2014Q1	us-gaap	Inventory Net InventoryNet	15178000
CY2014Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34960000
CY2014Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3917000
CY2014Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	5338000
CY2014Q1	us-gaap	Inventory Gross InventoryGross	18372000
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1383000
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3707000
CY2014Q1	us-gaap	Other Assets OtherAssets	194000
CY2014Q1	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	2120000
CY2014Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000
CY2014Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	23500000
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1673000
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	12463000
CY2014Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6798000
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7592000
CY2014Q1	alot	Line Of Credit Receivable Current LineOfCreditReceivableCurrent	240000
CY2014Q1	alot	Contract Related To Noncompete Agreement ContractRelatedToNoncompeteAgreement	250000
CY2012Q1	alot	Loan Receivable Interest Rate Stated Percentage LoanReceivableInterestRateStatedPercentage	0.0375	pure
	dei	Trading Symbol TradingSymbol	ALOT
	dei	Entity Registrant Name EntityRegistrantName	ASTRO MED INC /NEW/
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-08-02
	dei	Entity Central Index Key EntityCentralIndexKey	0000008146
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	5834	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7245	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7883000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.268	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	10.07
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	230706	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>(1) Overview</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada and Europe as well as with independent dealers and representatives. Astro-Med, Inc. products are sold under the brand names Astro-Med <sup style="font-size:85%; vertical-align:top">®</sup> Test & Measurement and QuickLabel <sup style="font-size:85%; vertical-align:top">®</sup> Systems and are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Unless otherwise indicated, references to “Astro-Med,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.</p> </div>
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	9.21
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.020	pure
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2370000
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	1592	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	150600	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.80
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7652000	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	10787	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	183143	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.33
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	150000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	23162	shares
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2564000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-41000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2521000
	us-gaap	Gross Profit GrossProfit	18225000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3825000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2776000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3945000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1076000
	us-gaap	Operating Income Loss OperatingIncomeLoss	3863000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2709000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	982000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38000
	us-gaap	Net Income Loss NetIncomeLoss	2564000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	845000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-43000
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-43000
	us-gaap	Sales Revenue Net SalesRevenueNet	43140000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	874000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	903000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-191000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2634000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-173000
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	24915000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	51000
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	259000
	us-gaap	Share Based Compensation ShareBasedCompensation	259000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4858000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8878000
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1555000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7401000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2850000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1038000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	7900000
	us-gaap	Operating Expenses OperatingExpenses	14362000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1261000
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1800000
	alot	Income Tax Expense IncomeTaxExpense	1361000
	alot	Agreement Expiration Date AgreementExpirationDate	2014-01-31
	alot	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	1	Equity_Plan
	alot	Number Of Installments NumberOfInstallments	16	Installment
	alot	Fees To Non Employee Director FeesToNonEmployeeDirector	7000
	alot	Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition	100000
	alot	Non Employee Director Received Restricted Stock Award Value NonEmployeeDirectorReceivedRestrictedStockAwardValue	20000
	alot	Reservation Of Shares Under Employee Stock Purchase Plan ReservationOfSharesUnderEmployeeStockPurchasePlan	247500	shares
	alot	Transition Services Period Maximum TransitionServicesPeriodMaximum	P12M
	alot	Product Replacement Related Costs ProductReplacementRelatedCosts
	alot	Loan Receivable Date Considered For Interest Payments LoanReceivableDateConsideredForInterestPayments	2013-01-30
	alot	Effective Tax Rate Current Year EffectiveTaxRateCurrentYear	0.330	pure
	alot	Effective Tax Rate Prior Year EffectiveTaxRatePriorYear	0.107	pure
	alot	Maximum Disposal Restriction As Percentage Of Restricted Stock Units MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits	0.50	pure
	alot	Period To Receive Lower Product Prices From Supplier PeriodToReceiveLowerProductPricesFromSupplier	P3Y
	alot	Discontinued Operations Amount Received From Disposition Of Inventory DiscontinuedOperationsAmountReceivedFromDispositionOfInventory	-2355000
	alot	Payments Received On Line Of Credit And Note Receivable PaymentsReceivedOnLineOfCreditAndNoteReceivable	165000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7617000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.383	pure
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	187565	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.026	pure
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6187000
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2266	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7429000	shares
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	173300	shares
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	3716000
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1303000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	489000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	188000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	58000
	us-gaap	Gross Profit GrossProfit	12027000
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	155000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	103000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4751000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	17835000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1047000
	us-gaap	Operating Income Loss OperatingIncomeLoss	165000
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	92000
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	378000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-193000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	535000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	288000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-62000
	us-gaap	Net Income Loss NetIncomeLoss	247000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2118000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-189000
	us-gaap	Sales Revenue Net SalesRevenueNet	32679000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	374000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2521000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-558000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	19980000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	59000
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	273000
	us-gaap	Share Based Compensation ShareBasedCompensation	273000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18816000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6954000
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4649000
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	87000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12071000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2387000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	636000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5950000
	us-gaap	Operating Expenses OperatingExpenses	11862000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000
	alot	Product Replacement Related Costs ProductReplacementRelatedCosts	672000
	alot	Payments Received On Line Of Credit And Note Receivable PaymentsReceivedOnLineOfCreditAndNoteReceivable	188000
CY2014Q1	alot	Settlement Amount Received From Supplier For Recovery Of Cost And Expenses SettlementAmountReceivedFromSupplierForRecoveryOfCostAndExpenses	450000
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2013Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	887000
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	531000
CY2013Q3	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	327000
CY2013Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	165000
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	862000
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7655000	shares
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	197332	shares
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.79
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7458000	shares
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
CY2013Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	173300	shares
CY2013Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	1965000
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	662000
CY2013Q3	us-gaap	Gross Profit GrossProfit	6923000
CY2013Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-39000
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25000
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	696000
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34000
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	17194000
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	5000
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1380000
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	10271000
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	113000
CY2013Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3382000
CY2013Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	94000
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1274000
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	6036000
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	331000
CY2013Q3	alot	Product Replacement Related Costs ProductReplacementRelatedCosts
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2014Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7916000	shares
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	212176	shares
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.84
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.19
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7704000	shares
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.18
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	150000	shares
CY2014Q3	us-gaap	Gross Profit GrossProfit	9589000
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	7425000
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1479000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2247000
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2164000
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1435000
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-133000
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	83000
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	1435000
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-132000
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	22366000
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1443000
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12777000
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	128000
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4503000
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	812000
CY2014Q3	alot	Product Replacement Related Costs ProductReplacementRelatedCosts
CY2014Q3	alot	Effective Tax Rate Current Year EffectiveTaxRateCurrentYear	0.361	pure
CY2014Q3	alot	Effective Tax Rate Prior Year EffectiveTaxRatePriorYear	0.384	pure
CY2014Q3	alot	Developments Affecting Unrecognized Tax Benefits DevelopmentsAffectingUnrecognizedTaxBenefits	0
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.93
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.79

Files In Submission

Name	View Source	Status
0001193125-14-336721-index-headers.html	Edgar Link	pending
0001193125-14-336721-index.html	Edgar Link	pending
0001193125-14-336721.txt	Edgar Link	pending
0001193125-14-336721-xbrl.zip	Edgar Link	pending
alot-20140802.xml	Edgar Link	completed
alot-20140802.xsd	Edgar Link	pending
alot-20140802_cal.xml	Edgar Link	unprocessable
alot-20140802_def.xml	Edgar Link	unprocessable
alot-20140802_lab.xml	Edgar Link	unprocessable
alot-20140802_pre.xml	Edgar Link	unprocessable
d766485d10q.htm	Edgar Link	pending
d766485dex311.htm	Edgar Link	pending
d766485dex312.htm	Edgar Link	pending
d766485dex321.htm	Edgar Link	pending
d766485dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALOT
AstroNova, Inc. Stock $alot

2014 Q3 Form 10-Q Financial Statement

#000119312514336721 Filed on September 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALOT AstroNova, Inc. Stock $alot

2014 Q3 Form 10-Q Financial Statement

#000119312514336721 Filed on September 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALOT
AstroNova, Inc. Stock $alot